论文部分内容阅读
目的 :分析我院肺癌治疗用药使用状况和发展趋势。方法 :以药品消耗金额为量变参数 ,对我院 2 0 0 0年～ 2 0 0 2年肺癌用药的药物消费结构进行调研 ,同时阐述了这些药物的国内外应用现状及发展趋势。结果 :一些较新的药物 (吉西他滨、紫杉醇、多西紫杉醇、异长春花碱 )在肺癌的一线、二线治疗上显示极具前途的作用 ,所以这些药物消费金额的增长明显超过肺癌用药消费总金额的增长。结论 :新药物的应用将成为肺癌药物治疗的主要趋势。
Objective: To analyze the use status and development trend of the treatment of lung cancer in our hospital. Methods: Taking the amount of drug consumption as a quantitative variable, we investigated the consumption structure of drugs for lung cancer in our hospital from 2000 to 2002, and described the current application and development trend of these drugs both at home and abroad. RESULTS: Some of the newer drugs (gemcitabine, paclitaxel, docetaxel, and vincapine) have shown promising effects in first- and second-line treatment of lung cancer, so the increase in the amount of these drugs consumed significantly outweighs the total cost of consumption of lung cancer growth of. Conclusion: The application of new drugs will become the main trend of drug treatment of lung cancer.